Journal News

MCP: When mitochondria make B cells go bad

John Arnst
Feb. 1, 2018

B-cell chronic lymphocytic leukemia, or B-CLL, is the most common type of leukemia in adults and primarily affects elderly patients. The disease results from a patient’s bone marrow overproducing immature lymphocytes, a form of white blood cells that fight infections less effectively than their healthy counterparts but survive longer, ultimately overwhelming them and spreading unchecked. Unlike acute leukemia, B-CLL can take several years to cause problems for a patient, but it is less responsive to chemotherapy.

When mitochondria, highlighted here in cow cells, suffer age-related oxidative damage, they can give rise to chronic lymphocytic leukemia.courtesy of Torsten Wittmann, University of California, San Francisco

While novel treatments have been developed in recent years, they only target the B cells once they’ve mutated to an immature, cancerous state. To develop treatments for B-CLL that might prevent B cells from becoming cancerous in the first place, researchers led by Christopher Gerner at the University of Vienna and Vienna Metabolomics Center have performed a comprehensive proteomics analysis of B-CLL cells and mature B cells in young and elderly patients. They described their work in a paper in the journal Molecular & Cellular Proteomics.

“It could be nice to not only target the cancer cells, but those cells prone to becoming cancer cells,” Gerner said. “What we actually saw when we compared the young and the elderly donors was a very clear signature of mitochondrial stress and metabolic stress.”

Gerner and colleagues found that B-CLL cells have an increased expression of stem cell-associated molecules and a reduced expression of tumor-suppressing molecules and stress-related serotonin transporters as well as an observed increase in glutamine consumption and beta-oxidation of fatty acid.

This indicated that reactive oxidative species, which are carcinogenic and cause damage to cells, were being upregulated, Gerner said, which would explain why the incidence of mutations that lead to B-CLL increases with age. The researchers hope that the alterations in regulation also may provide a proteomic signature for immunosenescence, the immune system’s natural weakening with age.

Gerner and his fellow researchers plan to continue this research by performing their proteomic analysis on blood samples taken from greater numbers of healthy elderly people and B-CLL patients to ultimatelybe able to test when mitochondria have become predisposed for the disease.

“The pressure on those cells was simply different … and this pressure is something I would like to detect and measure in patients,” Gerner said. “That would be the ultimate aim.”

John Arnst

John Arnst was a science writer for ASBMB Today.

Related articles

From the journals: MCP
Nuala Del Piccolo
From the journals: MCP
Nuala Del Piccolo & Laurel Oldach
From the journals: MCP
Kian Kamgar-Parsi
From the journals: MCP
Nivedita Uday Hegdekar

Join the ASBMB Today mailing list

Sign up to get updates on articles, interviews and events.

Latest in Science

Science highlights or most popular articles

From the journals: JLR
Journal News

From the journals: JLR

July 29, 2021

Reversing alcoholism’s effects on lipid droplets. How HDL cholesterol might reduce COVID-19 risk. Shining light on the cholesterol–GPCR relationship. Read about recent papers on these topics in the Journal of Lipid Research.

Starved to death: Can dietary methionine combat cancer?
Journal News

Starved to death: Can dietary methionine combat cancer?

July 27, 2021

Scientists draw a connection between this essential amino acid and cancer lipid metabolism.

I’m fully vaccinated but feel sick – should I get tested for COVID-19?
News

I’m fully vaccinated but feel sick – should I get tested for COVID-19?

July 25, 2021

It’s impossible to know whether a vaccinated person is fully protected or could still develop a mild case if exposed to the coronavirus.

Research roundup: Olympics edition
Observance

Research roundup: Olympics edition

July 23, 2021

A snapshot of science relevant to sports in the spotlight at the Tokyo Games.

A collaboration to study host immunity in plants and animals
Journal News

A collaboration to study host immunity in plants and animals

July 22, 2021

Characterizing chemokine function in plants may help researchers identify the protein’s role in humans.

Tour de flippase
Lipid News

Tour de flippase

July 20, 2021

These proteins — along with their siblings, floppases and scramblases — catalyze the flip-flop movement of phospholipid between the two leaflets of a membrane.